FDA Guidance Recap Podcast

Guidance Recap Podcast | Multiple Endpoints in Clinical Trials

FDA Guidance Recap Podcast

Show Notes

Guidance Recap Podcast | Multiple Endpoints in Clinical Trials

More from FDA Guidance Recap Podcast

Jul 7, 2026

Guidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations

Jun 22, 2026

Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development

Mar 25, 2026

Guidance Recap Podcast | Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products

Oct 22, 2025

Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

Oct 16, 2024

Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development

See all episodes →